Who Supplies Furosemide? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Furosemide exports, with 333+ registered manufacturers shipping to buyers across 150+ countries — yet a handful of companies dominate the shipments. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED holds the largest share at 19.2% (export value: $13.6M). Close behind, GRAVITI PHARMACEUTICALS PRIVATE LIMITED (16.6%, $11.7M). PFIZER HEALTHCARE INDIA PRIVATE LIMITED (3.9%, $2.8M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Furosemide? Top Manufacturers & Their Buyers
Flow of Furosemide from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Furosemide Supplier Network — Key Market Intelligence
The Furosemide export market from India is led by BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, which alone commands a 19.2% share, shipping $13.6M worth of product across 142 shipments. The second-largest exporter, GRAVITI PHARMACEUTICALS PRIVATE LIMITED, contributes $11.7M (16.6%) to the overall market. Combined, the top two suppliers alone account for 35.8% of all Furosemide exports, indicating a relatively concentrated supply base.
Across all 333 tracked manufacturers, the total Furosemide export value stands at $70.5M from 4.7K shipments. The market average shipment value is $15.1K. The single largest buyer relationship in terms of trade value is BAXTER HEALTHCARE CORPORATION., receiving $11.5M worth of product.
The combined buyer network spans 15 named purchasing companies, including BAXTER HEALTHCARE CORPORATION., STERIMAX INC, BAXTER DISTRIBUTION , BAXTER HEALTHCARE PT, RISING PHARMA HOLDINGS INC,., and 10 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED
BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is the first-largest Furosemide exporter from India, with a market share of 19.2% and a total export value of $13.6M across 142 shipments. Their average shipment value of $95.4K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED serves 5 named buyers in our database. BAXTER HEALTHCARE CORPORATION. is the dominant customer, accounting for 84.9% of this supplier's tracked business. Top customers include:
• BAXTER HEALTHCARE CORPORATION. — $11.5M across 121 shipments (84.9% of this supplier's total exports)
• BAXTER HEALTHCARE CORPORATION. — $960.7K across 10 shipments (7.1% of this supplier's total exports)
• STERIMAX INC — $690.3K across 7 shipments (5.1% of this supplier's total exports)
• BAXTER DISTRIBUTION — $259.0K across 3 shipments (1.9% of this supplier's total exports)
• BAXTER HEALTHCARE PT — $139.8K across 1 shipments (1.0% of this supplier's total exports)
Key Insight: BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED's per-shipment value of $95.4K is 530% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
2GRAVITI PHARMACEUTICALS PRIVATE LIMITED
GRAVITI PHARMACEUTICALS PRIVATE LIMITED is the second-largest Furosemide exporter from India, with a market share of 16.6% and a total export value of $11.7M across 1.7K shipments. Their average shipment value of $6.8K is below the market average of $15.1K, reflecting a high-volume, competitive pricing strategy.
GRAVITI PHARMACEUTICALS PRIVATE LIMITED serves 5 named buyers in our database. RISING PHARMA HOLDINGS INC,., is the dominant customer, accounting for 53.4% of this supplier's tracked business. Top customers include:
• RISING PHARMA HOLDINGS INC,., — $6.3M across 923 shipments (53.4% of this supplier's total exports)
• RISING PHARMA HOLDINGS INC,., — $4.2M across 616 shipments (35.7% of this supplier's total exports)
• RISING PHARMA HOLDINGS INC,., — $980.4K across 145 shipments (8.4% of this supplier's total exports)
• RISING PHARMA HOLDINGS INC,., — $151.7K across 22 shipments (1.3% of this supplier's total exports)
• RISING PHARMA HOLDINGS INC,., — $146.7K across 22 shipments (1.3% of this supplier's total exports)
Key Insight: GRAVITI PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (1.7K shipments) at a per-shipment value of $6.8K, indicating a broad distribution network with many smaller, regular orders.
3PFIZER HEALTHCARE INDIA PRIVATE LIMITED
PFIZER HEALTHCARE INDIA PRIVATE LIMITED is the third-largest Furosemide exporter from India, with a market share of 3.9% and a total export value of $2.8M across 13 shipments. Their average shipment value of $212.9K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
PFIZER HEALTHCARE INDIA PRIVATE LIMITED serves 2 named buyers in our database. HOSPIRA INC is the dominant customer, accounting for 67.8% of this supplier's tracked business. Top customers include:
• HOSPIRA INC — $1.9M across 9 shipments (67.8% of this supplier's total exports)
• XXSPIXX INX — $890.1K across 4 shipments (32.2% of this supplier's total exports)
Key Insight: PFIZER HEALTHCARE INDIA PRIVATE LIMITED's per-shipment value of $212.9K is 1305% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
4IPCA LABORATORIES LIMITED
IPCA LABORATORIES LIMITED is the fourth-largest Furosemide exporter from India, with a market share of 3.7% and a total export value of $2.6M across 72 shipments. Their average shipment value of $36.0K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
IPCA LABORATORIES LIMITED serves 5 named buyers in our database. NA is the dominant customer, accounting for 66.8% of this supplier's tracked business. Top customers include:
• NA — $1.7M across 48 shipments (66.8% of this supplier's total exports)
• TO THE ORDER — $350.7K across 10 shipments (13.5% of this supplier's total exports)
• MINT PHARMACEUTICALS INC — $271.8K across 8 shipments (10.5% of this supplier's total exports)
• MINT PHARMACEUTICALS INC — $143.9K across 4 shipments (5.6% of this supplier's total exports)
• IPCA LABORATORIES UK — $93.0K across 3 shipments (3.6% of this supplier's total exports)
Key Insight: IPCA LABORATORIES LIMITED's per-shipment value of $36.0K is 137% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
5MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the fifth-largest Furosemide exporter from India, with a market share of 3.0% and a total export value of $2.1M across 58 shipments. Their average shipment value of $36.3K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. VIATRIS SANTE is the dominant customer, accounting for 69.5% of this supplier's tracked business. Top customers include:
• VIATRIS SANTE — $1.5M across 40 shipments (69.5% of this supplier's total exports)
• VIATRIS SANTE — $241.1K across 7 shipments (11.5% of this supplier's total exports)
• CSP Viatris Sante at — $211.6K across 6 shipments (10.1% of this supplier's total exports)
• CSP VIATRIS SANT? AT — $104.5K across 3 shipments (5.0% of this supplier's total exports)
• CSP VIATRIS SANTE AT — $83.9K across 2 shipments (4.0% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $36.3K is 140% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
6AVET LIFESCIENCES PRIVATE LIMITED
AVET LIFESCIENCES PRIVATE LIMITED is the fifth-largest Furosemide exporter from India, with a market share of 2.6% and a total export value of $1.8M across 58 shipments. Their average shipment value of $31.9K is above the market average of $15.1K, suggesting premium or bulk contract pricing.
AVET LIFESCIENCES PRIVATE LIMITED serves 3 named buyers in our database. AVET PHARMACEUTICALS INC. is the dominant customer, accounting for 60.4% of this supplier's tracked business. Top customers include:
• AVET PHARMACEUTICALS INC. — $1.1M across 35 shipments (60.4% of this supplier's total exports)
• NORTHSTAR DISTRIBUTION CENTER — $570.9K across 18 shipments (30.9% of this supplier's total exports)
• AVET PHARMACEUTICALS INC. — $161.7K across 5 shipments (8.7% of this supplier's total exports)
Key Insight: AVET LIFESCIENCES PRIVATE LIMITED's per-shipment value of $31.9K is 110% above the market average of $15.1K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Furosemide Flows
Once Furosemide leaves the manufacturing plants of companies like BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED and GRAVITI PHARMACEUTICALS PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $70.5M. United States absorbs the largest share at 60.2% ($42.5M), followed by Canada (7.3%) and France (6.2%).
In United States — the top destination — named importers include BAXTER HEALTHCARE CORPORATION, RISING PHARMA HOLDINGS, INC., RISING PHARMA HOLDINGS INC. In Canada, key buyers are MARCAN PHARMACEUTICALS INC.,, STERIMAX INC, MINT PHARMACEUTICALS INC.
This geographic spread reflects Furosemide's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Furosemide Go? Top Importing Countries & Their Buyers
Trade flow of Furosemide exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Furosemide imports from India, with a total trade value of $42.5M across 1,889 shipments — representing a 60.2% share of all Furosemide exports. The average shipment value of $22.5K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.
Named Furosemide importers in United States: BAXTER HEALTHCARE CORPORATION is the largest buyer, accounting for 34.0% ($14.4M) of this market's total imports.
• BAXTER HEALTHCARE CORPORATION — $14.4M (34.0% of United States's total)
• RISING PHARMA HOLDINGS, INC. — $6.3M (14.7% of United States's total)
• RISING PHARMA HOLDINGS INC — $4.2M (9.8% of United States's total)
Key Insight: United States's per-shipment average of $22.5K (48% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Furosemide imports from India.
2Canada
Canada ranks as the second-largest destination for Furosemide imports from India, with a total trade value of $5.1M across 53 shipments — representing a 7.3% share of all Furosemide exports. The average shipment value of $96.8K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Furosemide importers in Canada: MARCAN PHARMACEUTICALS INC., is the largest buyer, accounting for 28.8% ($1.5M) of this market's total imports.
• MARCAN PHARMACEUTICALS INC., — $1.5M (28.8% of Canada's total)
• STERIMAX INC — $1.1M (21.9% of Canada's total)
• MINT PHARMACEUTICALS INC — $936.7K (18.3% of Canada's total)
Key Insight: Canada's per-shipment average of $96.8K (539% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Furosemide imports from India.
3France
France ranks as the third-largest destination for Furosemide imports from India, with a total trade value of $4.3M across 89 shipments — representing a 6.2% share of all Furosemide exports. The average shipment value of $48.9K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Furosemide importers in France: VIATRIS SANTE is the largest buyer, accounting for 36.3% ($1.6M) of this market's total imports.
• VIATRIS SANTE — $1.6M (36.3% of France's total)
• ARROW GENERIQUES, — $1.3M (28.9% of France's total)
Key Insight: France's per-shipment average of $48.9K (223% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Furosemide imports from India.
4Germany
Germany ranks as the fourth-largest destination for Furosemide imports from India, with a total trade value of $2.1M across 64 shipments — representing a 2.9% share of all Furosemide exports. The average shipment value of $32.2K is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Furosemide importers in Germany: SALUTAS PHARMA GMBH is the largest buyer, accounting for 100.0% ($2.1M) of this market's total imports.
• SALUTAS PHARMA GMBH — $2.1M (100.0% of Germany's total)
Key Insight: Germany's per-shipment average of $32.2K (112% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Germany is a key market for Furosemide imports from India.
5South Africa
South Africa ranks as the fifth-largest destination for Furosemide imports from India, with a total trade value of $1.6M across 0 shipments — representing a 2.2% share of all Furosemide exports. The average shipment value of $1.6M is above the global average of $15.1K, indicating high-value procurement contracts or branded formulations.
Key Insight: South Africa's per-shipment average of $1.6M (10332% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Furosemide imports from India.
People Also Ask — Furosemide Supplier & Trade Network
Who are the top suppliers of Furosemide from India?+
Which companies buy Furosemide from Indian manufacturers?+
Where does Furosemide exported from India go?+
What is the market share of the top Furosemide supplier from India?+
What is the average shipment value for Furosemide exports from India?+
Is Furosemide manufactured in India and exported globally?+
Which country imports the most Furosemide from India?+
Who are the buyers of Furosemide in Canada?+
How concentrated is the Furosemide supplier market in India?+
How do I find verified buyers for Furosemide in specific countries?+
Furosemide Trade Network — Key Takeaways
- 1BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED is India's dominant Furosemide exporter with a 19.2% market share and $13.6M in total exports — making it the single most important sourcing entity in this market.
- 2The top 333 suppliers collectively account for 49.0% of all tracked Furosemide exports, with a combined trade value of $70.5M.
- 3United States is the largest destination market, absorbing 60.2% of India's Furosemide exports ($42.5M). Canada (7.3%) and France (6.2%) follow.
- 4With 4.7K total shipments averaging $15.1K each, the Furosemide export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include BAXTER HEALTHCARE CORPORATION., BAXTER HEALTHCARE CORPORATION., RISING PHARMA HOLDINGS INC,.,, RISING PHARMA HOLDINGS INC,., — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 150 countries
Network value: $70.5M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Furosemide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Furosemide.
- 2.Flow Mapping: 333 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 4,657 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 150 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,657 Verified Shipments
333 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists